Lexaria Bioscience Corp Stock Price To Earning
| LEXX Stock | USD 2.29 0.08 3.38% |
Lexaria Bioscience Corp fundamentals help investors to digest information that contributes to Lexaria Bioscience's financial success or failures. It also enables traders to predict the movement of Lexaria Stock. The fundamental analysis module provides a way to measure Lexaria Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lexaria Bioscience stock.
Lexaria | Price To Earning |
Lexaria Bioscience Corp Company Price To Earning Analysis
Lexaria Bioscience's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Lexaria Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Lexaria Bioscience is extremely important. It helps to project a fair market value of Lexaria Stock properly, considering its historical fundamentals such as Price To Earning. Since Lexaria Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lexaria Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lexaria Bioscience's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Lexaria Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, Lexaria Bioscience Corp has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
Lexaria Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lexaria Bioscience's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lexaria Bioscience could also be used in its relative valuation, which is a method of valuing Lexaria Bioscience by comparing valuation metrics of similar companies.Lexaria Bioscience is currently under evaluation in price to earning category among its peers.
Lexaria Bioscience Current Valuation Drivers
We derive many important indicators used in calculating different scores of Lexaria Bioscience from analyzing Lexaria Bioscience's financial statements. These drivers represent accounts that assess Lexaria Bioscience's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Lexaria Bioscience's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 12.4M | 27.3M | 17.4M | 6.9M | 48.4M | 115.2M | |
| Enterprise Value | 11.3M | 16.5M | 11.7M | 5.8M | 42.1M | 116.4M |
Lexaria Bioscience ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Lexaria Bioscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Lexaria Bioscience's managers, analysts, and investors.Environmental | Governance | Social |
Lexaria Fundamentals
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.38 | ||||
| Operating Margin | (20.75) % | ||||
| Current Valuation | 33.55 M | ||||
| Shares Outstanding | 17.45 M | ||||
| Shares Owned By Insiders | 7.00 % | ||||
| Shares Owned By Institutions | 6.00 % | ||||
| Number Of Shares Shorted | 499.33 K | ||||
| Price To Book | 4.97 X | ||||
| Price To Sales | 97.24 X | ||||
| Revenue | 464.28 K | ||||
| Gross Profit | 183.56 K | ||||
| EBITDA | (5.68 M) | ||||
| Net Income | (5.81 M) | ||||
| Cash And Equivalents | 7.34 M | ||||
| Cash Per Share | 1.23 X | ||||
| Total Debt | 137.37 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 40.09 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (4.96 M) | ||||
| Short Ratio | 2.34 X | ||||
| Earnings Per Share | (0.47) X | ||||
| Target Price | 10.0 | ||||
| Beta | 1.06 | ||||
| Market Capitalization | 39.97 M | ||||
| Total Asset | 8.87 M | ||||
| Retained Earnings | (51.56 M) | ||||
| Working Capital | 1.93 M | ||||
| Net Asset | 8.87 M |
About Lexaria Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lexaria Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lexaria Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lexaria Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.